REPLIGEN CORPORATION - COMMON STOCK

Repligen to Report Third Quarter 2023 Financial Results

17 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

02 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova

26 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Appoints Jason K. Garland as Chief Financial Officer

12 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Corporation to Present at Wells Fargo Healthcare Conference

01 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification

17 Aug 2023 08:00:00 By Nasdaq GlobeNewswire

Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

02 Aug 2023 07:30:01 By Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2023 Financial Results

19 Jul 2023 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK

06 Jul 2023 09:48:50 By NetDania Notify

NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK

28 Jun 2023 09:45:03 By NetDania Notify

NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK

27 Jun 2023 09:53:09 By NetDania Notify

Repligen Corporation to Present at Upcoming Investor Conferences

31 May 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

02 May 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen to Report First Quarter 2023 Financial Results

18 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

14 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2022 Financial Results

22 Feb 2023 07:30:01 By Nasdaq GlobeNewswire

Repligen Appoints Martin D. Madaus to Board of Directors

09 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2022 Financial Results

08 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 07:30:00 By Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

08 Nov 2022 07:30:00 By Nasdaq GlobeNewswire